NCT07477314

Brief Summary

Women seeking asylum (WSA) are overexposed to sexual violence (SV) in their countries of origin, along migration routes, and within host countries. This overexposure does not cease upon arrival in host countries; on the contrary, the first months following arrival are characterised by heightened vulnerability, with an increased incidence of sexual violence, particularly among women with a prior history of victimisation. Sexual violence has major consequences on physical health, mental health, quality of life, and healthcare utilisation, and generates substantial individual and societal costs. International organisations, including the United Nations High Commissioner for Refugees, have identified the prevention of sexual violence and the improvement of care for survivors as public health priorities. Previous work suggests that addressing sexual violence within primary care, when embedded in a comprehensive, culturally informed, and coordinated approach integrating medical, psychological, social, and medico-legal dimensions, may contribute to preventing the occurrence or recurrence of sexual violence in host countries. However, no comparative study has yet evaluated the effectiveness of such a coordinated model of care on the prevention of sexual violence among women seeking asylum, nor assessed its efficiency or transferability. The primary objective of this study is to evaluate the effectiveness of a coordinated, transcultural, multidisciplinary outpatient care model on the prevention of sexual violence occurring in host European countries among women seeking asylum.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
675

participants targeted

Target at P75+ for all trials

Timeline
25mo left

Started Apr 2026

Typical duration for all trials

Geographic Reach
1 country

6 active sites

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress14%
Apr 2026Sep 2028

First Submitted

Initial submission to the registry

February 16, 2026

Completed
29 days until next milestone

First Posted

Study publicly available on registry

March 17, 2026

Completed
15 days until next milestone

Study Start

First participant enrolled

April 1, 2026

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2028

Expected
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2028

Last Updated

March 19, 2026

Status Verified

March 1, 2026

Enrollment Period

2 years

First QC Date

February 16, 2026

Last Update Submit

March 17, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Occurrence of sexual violence within 12 months after inclusion

    The primary outcome is the occurrence of sexual violence during the first 12 months following inclusion. Sexual violence is defined as the occurrence of at least one of the following events: rape, attempted rape, sexual assault, or sexual exhibition, as assessed through structured interviews administered at follow-up visits.

    12 months after inclusion

Secondary Outcomes (46)

  • Occurrence of rape within 12 months after inclusion

    12 months after inclusion

  • Occurrence of sexual violence between 12 and 18 months after inclusion

    12 to 18 months after inclusion

  • Occurrence of rape between 12 and 18 months after inclusion

    12 to 18 months after inclusion

  • Measurement and Assessment of somatic symptoms

    at Baseline

  • Measurement and Assessment of somatic symptoms

    at 3 months

  • +41 more secondary outcomes

Study Arms (2)

Coordinated care model

The coordinated outpatient care model is initiated through early identification at reception platforms by a dedicated mobile team and delivered over 12 months. It is based on proactive detection of sexual violence and structured coordination of care aimed at addressing its consequences and preventing recurrence. Through this coordination, the model aims to improve early access to care, continuity of follow-up, patient engagement, and effective mobilisation of existing services, including primary care, mental health services, sexual and reproductive health services, social support, and legal assistance when required.

Other: care coordinatorOther: a trained health mediatorOther: Access to care in the usual careOther: CoordinationOther: Detection of sexual violenceOther: Medical follow-upOther: Training of professionals

Comparator - Usual care

Participants in the comparator group receive usual care as implemented locally, which may include access to emergency or institutional services, primary care, or specialised structures, but without systematic coordination or proactive outreach.

Other: Access to care in the Coordinated care modelOther: CoordinationOther: Detection of sexual violenceOther: Medical follow-upOther: Training of professionals

Interventions

The care coordinator ensures organisation of the care pathway, liaison between professionals, and longitudinal follow-up in collaboration with a general practitioner.

Coordinated care model

The health mediator facilitates communication, supports participants in navigating healthcare and social systems, and helps reduce linguistic, cultural, and administrative barriers.

Coordinated care model

Depends on asylum seekers' individual initiatives

Coordinated care model

Systematically initiated from registration at the first reception centre (PADA)

Comparator - Usual care

Fragmented, dependent on local structures

Comparator - Usual care

Based on victims' self-reporting

Comparator - Usual care

Irregular, often interrupted due to precarious living conditions

Comparator - Usual care

Variable, not standardized

Comparator - Usual care

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Female seeking asylum in France

You may qualify if:

  • Woman seeking asylum in France
  • Self-identified female gender.
  • Age ≥ 18 years.
  • Received study information and provided informed consent to participate

You may not qualify if:

  • Re-examination of a previous asylum application.
  • Major cognitive impairment (e.g. dementia or intellectual disability) preventing reliable collection of study outcomes.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (6)

Maison de Santé de Saint André

Bordeaux, France

Location

MSP soins premiers Villeurbanne Est

Lyon, France

Location

Maison de Santé PEYSSONEL

Marseille, France

Location

Maison de Santé Butte Sainte Anne

Nantes, France

Location

MSP Mathagon

Paris, France

Location

Maison de santé Bonnefoy Périole Roseraie

Toulouse, France

Location

MeSH Terms

Conditions

Psychological Well-Being

Interventions

Health Services Accessibility

Condition Hierarchy (Ancestors)

Personal SatisfactionBehavior

Intervention Hierarchy (Ancestors)

Delivery of Health CarePatient Care ManagementHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Study Officials

  • François Crémieux

    AP-HM

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 16, 2026

First Posted

March 17, 2026

Study Start

April 1, 2026

Primary Completion (Estimated)

April 1, 2028

Study Completion (Estimated)

September 1, 2028

Last Updated

March 19, 2026

Record last verified: 2026-03

Locations